ESMO Academy 2026
The ESMO Academy 2026, organized by the European Society for Medical Oncology (ESMO), will take place virtually from 3 August to 12 October 2026. The programme will combine on-demand educational […]
The ESMO Academy 2026, organized by the European Society for Medical Oncology (ESMO), will take place virtually from 3 August to 12 October 2026. The programme will combine on-demand educational […]
The ESMO Deep Dive: First-Line Therapy for HRD-Negative Advanced Ovarian Cancer 2026 webinar, organized by the European Society for Medical Oncology (ESMO), will take place live on 2 September 2026 […]
The “Optimising Antibody–Drug Conjugate Safety: Mechanisms, Monitoring and Management of Toxicities 2026” webinar, organized by the European Society for Medical Oncology (ESMO), will take place on September 9, 2026, at […]
The Molecular Analysis for Precision Oncology (MAP) Congress 2026, co-organized by the European Society for Medical Oncology (ESMO), Cancer Research UK (CRUK), and Unicancer, is scheduled for 10–11 September 2026 […]
The ESMO Preceptorship on Tumour-agnostic and Cancer of Unknown Primary 2026 is scheduled to take place in Zurich, Switzerland, from September 18–19, 2026. Chaired by Natalie Cook and Benedikt Westphalen, […]
The ESMO Preceptorship on Supportive Care Needs and Cachexia Management in Cancer Patients 2026, organized by the European Society for Medical Oncology (ESMO), will take place on 29–30 September 2026 […]
The ESMO Guidelines: Real World Cases - Webinar Series: Uveal Melanoma 2026 is scheduled for Wednesday, September 30, 2026, starting at 18:30 CEST. As uveal melanoma remains a rare and […]
The ESMO Guidelines: Real World Cases Webinar – Early Stage and Locally Advanced NSCLC 2026, organized by the European Society for Medical Oncology (ESMO), will take place on September 30, […]
The ESMO Advanced Course on Precision Treatment Sequencing in Metastatic Breast Cancer 2026, organized by the European Society for Medical Oncology (ESMO), will take place on 2–3 October 2026 in […]
The ESMO Advanced Course on Optimising Treatment Sequencing in Advanced NSCLC 2026, oorganized by the European Society for Medical Oncology (ESMO), will take place on 2–3 October 2026 in Singapore. […]
The ESMO Deep Dive: Gynaecological Cancers – The Evolving Landscape in the Treatment of Relapsed Ovarian Cancer 2026, organized by the European Society for Medical Oncology (ESMO), will take place […]
The ESMO Congress Highlights Webinar: Gastrointestinal Cancers 2026, organized by the European Society for Medical Oncology (ESMO), will take place online on November 9, 2026, at 18:30 CET. The webinar […]
The ESMO Advanced Course on Brain Metastases in Lung and Breast Cancer 2026: Barcelona is scheduled to take place in Barcelona, Spain, from November 11–12, 2026. This specialized educational program is co-chaired by Simon Ekman, Lizza Hendriks, and Natasha Leighl, and focuses on providing oncologists with high-level training on the evolving diagnostic and therapeutic strategies […]
The ESMO Advanced Course on Cholangiocarcinoma 2026, organized by the European Society for Medical Oncology (ESMO), will take place on November 13–14, 2026, in Barcelona, Spain. The course is designed to provide an advanced multidisciplinary update on the diagnosis and management of cholangiocarcinoma, covering diagnostic challenges, clinical and molecular differences between disease subtypes, adjuvant and […]
The ESMO AI and Digital Oncology Congress 2026 will take place from November 16-18, 2026, in Berlin, Germany. This congress is designed as a central meeting point that facilitates the exchange of the latest research, promotes ethical dialogue, and highlights technological innovation in cancer care. It brings together healthcare and digital health experts from around […]
The ESMO Deep Dive: Gynaecological Cancers – Are We Defeating Cervical Cancer? 2026, organized by the European Society for Medical Oncology (ESMO), will take place on November 18, 2026, at 6:30 PM CET (9:30 PM AMT) as a live virtual webinar. The session will review recent progress and remaining challenges in cervical cancer management, including […]